Anemia Management News

While clinical trials have shown hypoxia-inducible factor prolyl hydroxylase inhibitors to be non-inferior to other anemia drugs, questions remain about IV or oral iron supplementation and inflammation, according to a new report.

Taking daily low-dose aspirin was linked to an increased incidence of anemia and a decline in blood iron levels among otherwise healthy older adults, according to the results of research published in Annals of Internal Medicine.

Intravenous iron therapy did not improve exercise capacity in nonanemic patients with iron deficiency who have chronic kidney disease, according to recently published data.

Akebia Therapeutics’ formal dispute resolution request was denied by the Office of New Drugs of the FDA for vadadustat in the treatment of anemia due to for dialysis-dependent patients, according to a press release.

Data from a North American registry show anemia can affect more than 75% of candidates for a left ventricular device implant and up to 67% of recipients in the years after implant, driving higher mortality risk and worse quality of life.

Akebia Therapeutics Inc. has received approval from the European Commission to market its oral hypoxia-inducible factor prolyl hydroxylase inhibitor Vafseo in Europe, according to a press release.

AUSTIN, Texas —An investigational treatment, DISC-0974, can reduce hepcidin and elevate iron levels in healthy patients, according to a presenter at the National Kidney Foundation Spring Clinical Meetings.

AUSTIN, Texas — Patients on dialysis face a host of issues that may lead to long-term depression and jeopardize their chances of getting a transplant, a speaker said here.

AUSTIN, Texas — Patients on dialysis who are hyporesponsive to anemia treatment will likely experience more red blood cell transfusions, according to data presented at the National Kidney Foundation Spring Clinical Meetings.

AUSTIN, Texas —Patients on dialysis who are hyporesponsive to anemia treatment have a higher risk for hospitalizations and death, according to data presented here.